CDEK
← All organizations

Kite Pharma, Inc.

For profitContributed to NMEWebsite ↗

Also known as: Kite Pharma | Kite Pharma Inc. | Kite Systems

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 1, 2015

First marketed drug

Oct 18, 2017

First NDA

Oct 18, 2017

Last known activity

Oct 2, 2023

Acquired by Gilead Sciences on Oct 3, 2017

Timeline

2000s

  1. Jul 1, 2009

    Kite Pharma, Inc.— Founded

2010s

  1. Oct 3, 2017

    Gilead Sciences— Acquired By

  2. Oct 18, 2017

    axicabtagene ciloleucel— NDA Organization

2020s

  1. Dec 20, 2022

    Tmunity Therapeutics— Acquired

Drugs by trial phase (12 distinct, 16 trials)

Phase 2 (2 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (19)

Details

Founded
Santa Monica, CA, US Jul 1, 2009
First NDA
Oct 18, 2017
Last known activity
Oct 2, 2023

Designations held

  • Orphan drug
  • Priority review
  • Breakthrough therapy